BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barturen G, Alarcón-Riquelme ME. SLE redefined on the basis of molecular pathways. Best Pract Res Clin Rheumatol 2017;31:291-305. [PMID: 29224672 DOI: 10.1016/j.berh.2017.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Ntasis VF, Panousis NI, Tektonidou MG, Dermitzakis ET, Boumpas DT, Bertsias GK, Nikolaou C. Extensive fragmentation and re-organization of transcription in Systemic Lupus Erythematosus. Sci Rep 2020;10:16648. [PMID: 33024230 DOI: 10.1038/s41598-020-73654-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Bangert E, Wakani L, Merchant M, Strand V, Touma Z. Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies. Patient Relat Outcome Meas 2019;10:1-7. [PMID: 30666173 DOI: 10.2147/PROM.S134326] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Gatto M, Zen M, Iaccarino L, Doria A. New therapeutic strategies in systemic lupus erythematosus management. Nat Rev Rheumatol 2019;15:30-48. [DOI: 10.1038/s41584-018-0133-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 58] [Article Influence: 10.0] [Reference Citation Analysis]